Literature DB >> 21521705

Linezolid: safety and efficacy in special populations.

F Kate Gould1.   

Abstract

Linezolid has been in general use in the UK since 2000. Although toxicity, particularly haematological and neurological, has been an issue, linezolid has proved to be an effective alternative to glycopeptides in the treatment of Gram-positive infections. Since its original licence for the treatment of skin and soft tissue infections and pneumonia, there have been reports of its successful use in the treatment of bone and joint infections, endocarditis, and other difficult-to-treat infections.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21521705     DOI： 10.1093/jac/dkr071

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  8 in total

Review 1.  MRSA: treating people with infection.

Authors:  Nikolas Rae; Anna Jarchow-MacDonald; Dilip Nathwani; Charis Ann Marwick
Journal:  BMJ Clin Evid       Date:  2016-02-16

2.  Linezolid as rescue treatment for left-sided infective endocarditis: an observational, retrospective, multicenter study.

Authors:  T K Lauridsen; L E Bruun; R V Rasmussen; M Arpi; N Risum; C Moser; H K Johansen; H Bundgaard; C Hassager; N E Bruun
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-20       Impact factor: 3.267

3.  Activity of Tedizolid in Methicillin-Resistant Staphylococcus epidermidis Experimental Foreign Body-Associated Osteomyelitis.

Authors:  Kyung-Hwa Park; Kerryl E Greenwood-Quaintance; Audrey N Schuetz; Jayawant N Mandrekar; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

4.  A comparison of different antibiotic regimens for the treatment of infective endocarditis.

Authors:  Arturo J Martí-Carvajal; Mark Dayer; Lucieni O Conterno; Alejandro G Gonzalez Garay; Cristina Elena Martí-Amarista
Journal:  Cochrane Database Syst Rev       Date:  2020-05-14

5.  Activity of Tedizolid in Methicillin-Resistant Staphylococcus aureus Experimental Foreign Body-Associated Osteomyelitis.

Authors:  Kyung-Hwa Park; Kerryl E Greenwood-Quaintance; Jayawant Mandrekar; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

6.  Efficacy and safety of linezolid in treating gram-positive bacterial infection in the elderly: a retrospective study.

Authors:  Zhi-Yong Zhou; Xue-Qin Zhao; Bao-Zhong Shan; Jie Zhu; Xiang Zhang; Qing-Fen Tian; De-Fang Chen; Tang-Hong Jia
Journal:  Indian J Microbiol       Date:  2013-08-03       Impact factor: 2.461

Review 7.  Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections.

Authors:  Olivia Ferrández; Olatz Urbina; Santiago Grau
Journal:  Drug Des Devel Ther       Date:  2016-12-22       Impact factor: 4.162

8.  Incidence, risk factors and prediction of post-operative acute kidney injury following cardiac surgery for active infective endocarditis: an observational study.

Authors:  Matthieu Legrand; Romain Pirracchio; Anne Rosa; Maya L Petersen; Mark Van der Laan; Jean-Noël Fabiani; Marie-paule Fernandez-gerlinger; Isabelle Podglajen; Denis Safran; Bernard Cholley; Jean-Luc Mainardi
Journal:  Crit Care       Date:  2013-10-04       Impact factor: 9.097
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.